2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol

C92H91N23O6 — CID 159162301

IUPAC2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol
SMILESOc1cc(-n2cccn2)ccc1-c1ccc(C2=CCNCC2)nn1.Oc1cc(-n2cccn2)ccc1-c1ccc(C2CCNCC2)nn1.Oc1cc(-n2cccn2)ccc1-c1ccc(N2C[C@H]3CNC[C@H]3C2)nn1.Oc1cc2ccccc2cc1-c1ccc(C2=CCNCC2)nn1.Oc1ccc2cc(-c3ccc(N4CCNCC4)nn3)c(O)cc2c1
InChIInChI=1S/C19H20N6O.C19H17N3O.C18H19N5O.C18H17N5O.C18H18N4O2/c26-18-8-15(25-7-1-6-21-25)2-3-16(18)17-4-5-19(23-22-17)24-11-13-9-20-10-14(13)12-24;23-19-12-15-4-2-1-3-14(15)11-16(19)18-6-5-17(21-22-18)13-7-9-20-10-8-13;2*24-18-12-14(23-11-1-8-20-23)2-3-15(18)17-5-4-16(21-22-17)13-6-9-19-10-7-13;23-14-2-1-12-10-15(17(24)11-13(12)9-14)16-3-4-18(21-20-16)22-7-5-19-6-8-22/h1-8,13-14,20,26H,9-12H2;1-7,11-12,20,23H,8-10H2;1-5,8,11-13,19,24H,6-7,9-10H2;1-6,8,11-12,19,24H,7,9-10H2;1-4,9-11,19,23-24H,5-8H2/t13-,14+;;;;
InChIKeyKKQJPNLLLLBLGK-LSZCJTLMSA-N
MW1614.89 g/mol
LogP12.10
Rot. Bonds13

About 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol

2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol (PubChem CID 159162301) has the molecular formula C92H91N23O6 and a molecular weight of 1614.89 g/mol. Its IUPAC name is 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol.

Molecular Properties

Compound Name2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol
PubChem CID159162301
Molecular FormulaC92H91N23O6
Molecular Weight1614.89 g/mol
Exact Mass1613.75
IUPAC Name2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol
SMILESOc1cc(-n2cccn2)ccc1-c1ccc(C2=CCNCC2)nn1.Oc1cc(-n2cccn2)ccc1-c1ccc(C2CCNCC2)nn1.Oc1cc(-n2cccn2)ccc1-c1ccc(N2C[C@H]3CNC[C@H]3C2)nn1.Oc1cc2ccccc2cc1-c1ccc(C2=CCNCC2)nn1.Oc1ccc2cc(-c3ccc(N4CCNCC4)nn3)c(O)cc2c1
InChIInChI=1S/C19H20N6O.C19H17N3O.C18H19N5O.C18H17N5O.C18H18N4O2/c26-18-8-15(25-7-1-6-21-25)2-3-16(18)17-4-5-19(23-22-17)24-11-13-9-20-10-14(13)12-24;23-19-12-15-4-2-1-3-14(15)11-16(19)18-6-5-17(21-22-18)13-7-9-20-10-8-13;2*24-18-12-14(23-11-1-8-20-23)2-3-15(18)17-5-4-16(21-22-17)13-6-9-19-10-7-13;23-14-2-1-12-10-15(17(24)11-13(12)9-14)16-3-4-18(21-20-16)22-7-5-19-6-8-22/h1-8,13-14,20,26H,9-12H2;1-7,11-12,20,23H,8-10H2;1-5,8,11-13,19,24H,6-7,9-10H2;1-6,8,11-12,19,24H,7,9-10H2;1-4,9-11,19,23-24H,5-8H2/t13-,14+;;;;
InChIKeyKKQJPNLLLLBLGK-LSZCJTLMSA-N
XLogP12.10
TPSA370.37 Ų
H-Bond Donors11
H-Bond Acceptors29
Rotatable Bonds13
Heavy Atoms121
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001614.89
LogP ≤ 512.10
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1029

Analyze 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol?
The IUPAC name of 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol (CID 159162301) is 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol.
What is the SMILES notation for 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol?
The canonical SMILES for 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol is Oc1cc(-n2cccn2)ccc1-c1ccc(C2=CCNCC2)nn1.Oc1cc(-n2cccn2)ccc1-c1ccc(C2CCNCC2)nn1.Oc1cc(-n2cccn2)ccc1-c1ccc(N2C[C@H]3CNC[C@H]3C2)nn1.Oc1cc2ccccc2cc1-c1ccc(C2=CCNCC2)nn1.Oc1ccc2cc(-c3ccc(N4CCNCC4)nn3)c(O)cc2c1.
What is the InChIKey of 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol?
The InChIKey is KKQJPNLLLLBLGK-LSZCJTLMSA-N. The full InChI is InChI=1S/C19H20N6O.C19H17N3O.C18H19N5O.C18H17N5O.C18H18N4O2/c26-18-8-15(25-7-1-6-21-25)2-3-16(18)17-4-5-19(23-22-17)24-11-13-9-20-10-14(13)12-24;23-19-12-15-4-2-1-3-14(15)11-16(19)18-6-5-17(21-22-18)13-7-9-20-10-8-13;2*24-18-12-14(23-11-1-8-20-23)2-3-15(18)17-5-4-16(21-22-17)13-6-9-19-10-7-13;23-14-2-1-12-10-15(17(24)11-13(12)9-14)16-3-4-18(21-20-16)22-7-5-19-6-8-22/h1-8,13-14,20,26H,9-12H2;1-7,11-12,20,23H,8-10H2;1-5,8,11-13,19,24H,6-7,9-10H2;1-6,8,11-12,19,24H,7,9-10H2;1-4,9-11,19,23-24H,5-8H2/t13-,14+;;;;.
What are the key properties of 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol?
2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol has a molecular weight of 1614.89 g/mol, XLogP of 12.10, 13 rotatable bonds, 11 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-[(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]pyridazin-3-yl]-5-pyrazol-1-ylphenol;3-(6-piperazin-1-ylpyridazin-3-yl)naphthalene-2,7-diol;2-(6-piperidin-4-ylpyridazin-3-yl)-5-pyrazol-1-ylphenol;5-pyrazol-1-yl-2-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]phenol;3-[6-(1,2,3,6-tetrahydropyridin-4-yl)pyridazin-3-yl]naphthalen-2-ol is sourced from PubChem (CID 159162301), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).